Aetresin LLC was founded in 2025 with a clear mandate: to bring senior-level CQV expertise directly to biopharmaceutical clients who need it most — without the overhead, bureaucracy, or diluted talent of large consulting firms.
The name Aetresin is a deliberate fusion — drawing from the founders' heritage and identity, forged into a single, distinctive mark that represents a new standard in validation consulting.
"Every protocol we write is a promise — to our clients, to patients, and to the integrity of the manufacturing process itself."
Our leadership brings five-plus years of hands-on GMP experience spanning large-scale biologics CDMOs, sterile manufacturing, specialty pharmaceuticals, and multi-site validation programs. We have personally authored and executed validation protocols across IQ/OQ/PQ, cleaning validation, MES platforms, and utility qualification — in environments where FDA inspection readiness is a daily operational standard.
We founded Aetresin to serve clients who want a true subject-matter expert in the room, not a project manager directing junior staff from a distance. Every engagement is led personally by our principals, ensuring consistency, accountability, and technical depth from kickoff through final report.
Based in Cary, North Carolina — in the heart of Research Triangle Park's thriving biopharma corridor — Aetresin is positioned to support both local clients and national engagements.